Cargando…
Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit the growth/pathogenicity of this bacterium, w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009973/ https://www.ncbi.nlm.nih.gov/pubmed/29098923 http://dx.doi.org/10.1080/14756366.2017.1388233 |
_version_ | 1783333503137480704 |
---|---|
author | Vullo, Daniela Kumar, R. Siva Sai Scozzafava, Andrea Ferry, James G. Supuran, Claudiu T. |
author_facet | Vullo, Daniela Kumar, R. Siva Sai Scozzafava, Andrea Ferry, James G. Supuran, Claudiu T. |
author_sort | Vullo, Daniela |
collection | PubMed |
description | The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit the growth/pathogenicity of this bacterium, we report here an inhibition study of this enzyme with a panel of aromatic, heterocyclic and sugar sulphonamides/sulphamates. Some sulphonamides, such as acetazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, sulthiame and 4-(2-hydroxymethyl-4-nitrophenyl-sulphonamido)ethylbenzenesulphonamide were effective CpeCA inhibitors, with K(I)s in the range of 37.4–71.6 nM. Zonisamide and saccharin were the least effective such inhibitors, whereas many other aromatic and heterocyclic sulphonamides were moderate – weak inhibitors with K(I)s ranging between 113 and 8755 nM. Thus, this study provides the basis for developing better clostridial enzyme inhibitors with potential as antiinfectives with a new mechanism of action. |
format | Online Article Text |
id | pubmed-6009973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-60099732018-07-11 Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens Vullo, Daniela Kumar, R. Siva Sai Scozzafava, Andrea Ferry, James G. Supuran, Claudiu T. J Enzyme Inhib Med Chem Research Paper The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit the growth/pathogenicity of this bacterium, we report here an inhibition study of this enzyme with a panel of aromatic, heterocyclic and sugar sulphonamides/sulphamates. Some sulphonamides, such as acetazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, sulthiame and 4-(2-hydroxymethyl-4-nitrophenyl-sulphonamido)ethylbenzenesulphonamide were effective CpeCA inhibitors, with K(I)s in the range of 37.4–71.6 nM. Zonisamide and saccharin were the least effective such inhibitors, whereas many other aromatic and heterocyclic sulphonamides were moderate – weak inhibitors with K(I)s ranging between 113 and 8755 nM. Thus, this study provides the basis for developing better clostridial enzyme inhibitors with potential as antiinfectives with a new mechanism of action. Taylor & Francis 2017-11-03 /pmc/articles/PMC6009973/ /pubmed/29098923 http://dx.doi.org/10.1080/14756366.2017.1388233 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Vullo, Daniela Kumar, R. Siva Sai Scozzafava, Andrea Ferry, James G. Supuran, Claudiu T. Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens |
title | Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens |
title_full | Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens |
title_fullStr | Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens |
title_full_unstemmed | Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens |
title_short | Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens |
title_sort | sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen clostridium perfringens |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009973/ https://www.ncbi.nlm.nih.gov/pubmed/29098923 http://dx.doi.org/10.1080/14756366.2017.1388233 |
work_keys_str_mv | AT vullodaniela sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens AT kumarrsivasai sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens AT scozzafavaandrea sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens AT ferryjamesg sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens AT supuranclaudiut sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens |